Literature DB >> 16648299

The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines.

V E MacRae1, C Farquharson, S F Ahmed.   

Abstract

Childhood chronic inflammatory disease can be associated with transient and permanent growth retardation. This study examined the potential for spontaneous growth recovery following pro-inflammatory cytokine exposure. Murine ATDC5 chondrogenic cells and postnatal metatarsals were exposed to interleukin (IL)-1beta, IL-6 and tumour necrosis factor-alpha (TNFalpha), and their growth and proliferative capacity were determined following recovery. TNFalpha and IL-1beta reduced chondrocyte proliferation and aggrecan and collagen types II and X expression at minimum concentrations of 10 ng/ml and 0.1 ng/ml respectively. TNFalpha but not IL-1beta exposure led to increased caspase-3 activity and altered cellular morphology, consistent with reduced viability. Cytokine exposure particularly inhibited proteoglycan synthesis. This effect was dose and duration dependent. Compared with the control, IL-1beta and TNFalpha led to a 71% and 45% reduction in metatarsal growth after 8 days of exposure respectively (P < 0.05). An additive effect of IL-1beta combined with TNFalpha was observed (110% decrease; P < 0.05). Metatarsals exposed to IL-1beta or TNFalpha individually for a 2-day period, and allowed to recover spontaneously in the absence of cytokines for a further 6 days, showed normal growth trajectories. In combination, growth was 59% lower (P < 0.01) compared with control metatarsals at the end of the recovery period. Exposure to the combination for 4 days followed by a 4-day recovery period resulted in 87% decrement compared with controls (P < 0.05). IL-6 did not alter any parameter studied. IL-1beta and TNFalpha exert diverse inhibitory effects on ATDC5 chondrocyte dynamics and metatarsal growth. The extent of recovery following cytokine exposure depends on the duration of exposure, and may be incomplete following longer periods of exposure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648299     DOI: 10.1677/joe.1.06609

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  38 in total

Review 1.  An update of the role of nutritional therapy in the management of Crohn's disease.

Authors:  Moftah H Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2012-06-15       Impact factor: 7.527

Review 2.  Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up.

Authors:  Alberto Roselló-Díez; Alexandra L Joyner
Journal:  Endocr Rev       Date:  2015-10-20       Impact factor: 19.871

Review 3.  Growth abnormalities in children and adolescents with juvenile idiopathic arthritis.

Authors:  Susanne Bechtold; Dominique Simon
Journal:  Rheumatol Int       Date:  2014-04-24       Impact factor: 2.631

Review 4.  Osteoporosis in chronic inflammatory disease: the role of malnutrition.

Authors:  Tiziana Montalcini; Stefano Romeo; Yvelise Ferro; Valeria Migliaccio; Carmine Gazzaruso; Arturo Pujia
Journal:  Endocrine       Date:  2012-10-09       Impact factor: 3.633

Review 5.  Short and tall stature: a new paradigm emerges.

Authors:  Jeffrey Baron; Lars Sävendahl; Francesco De Luca; Andrew Dauber; Moshe Phillip; Jan M Wit; Ola Nilsson
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

6.  IKKβ in postnatal perichondrium remotely controls endochondral ossification of the growth plate through downregulation of MCP-5.

Authors:  K Kobayashi; J Toguchida; M Karin; T Kato
Journal:  Cell Death Differ       Date:  2014-12-19       Impact factor: 15.828

7.  Effect of anakinra on arthropathy in CINCA/NOMID syndrome.

Authors:  Takako Miyamae; Yutaka Inaba; Gen Nishimura; Masako Kikuchi; Takayuki Kishi; Ryoki Hara; Utako Kaneko; Toshihiko Shinoki; Tomoyuki Imagawa; Shumpei Yokokta
Journal:  Pediatr Rheumatol Online J       Date:  2010-03-16       Impact factor: 3.054

8.  Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation.

Authors:  A J Brown; M Alicknavitch; S S D'Souza; T Daikoku; C B Kirn-Safran; D Marchetti; D D Carson; M C Farach-Carson
Journal:  Bone       Date:  2008-06-06       Impact factor: 4.398

9.  Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.

Authors:  Lomeli R Carpio; Elizabeth W Bradley; Meghan E McGee-Lawrence; Megan M Weivoda; Daniel D Poston; Amel Dudakovic; Ming Xu; Tamar Tchkonia; James L Kirkland; Andre J van Wijnen; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Sci Signal       Date:  2016-08-09       Impact factor: 8.192

10.  Postnatal progression of bone disease in the cervical spines of mucopolysaccharidosis I dogs.

Authors:  Joseph A Chiaro; Matthew D Baron; Chelsea M Del Alcazar; Patricia O'Donnell; Eileen M Shore; Dawn M Elliott; Katherine P Ponder; Mark E Haskins; Lachlan J Smith
Journal:  Bone       Date:  2013-04-04       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.